对于COVID-19感染的介质干细胞疗法
Seyyed Mohammad Matin Alavi-Dana1, Yazdan Gholami1, Mohammadreza Meghdadi2
1Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Inflammopharmacology
|December 20, 2023
概括
介质细胞干细胞 (MSC) 疗法通过减少炎症和细胞因子风暴来治疗COVID-19具有前景. 临床研究表明,MSC治疗是COVID-19感染患者的安全有效的新型治疗选择.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 传染性疾病 传染性疾病
背景情况:
- 全球大流行COVID-19已经造成了显著的死亡率.
- 目前的治疗方法旨在降低死亡率和管理严重症状.
- 介质细胞干细胞 (MSCs) 正在探索它们的治疗潜力.
研究的目的:
- 审查COVID-19的病变发生过程.
- 讨论MSCs在缓解COVID-19引起的炎症和细胞因子风暴中的作用.
- 评估MSC治疗COVID-19的安全性和有效性.
主要方法:
- 对COVID-19病变发生的临床前和临床研究的审查.
- 对抑制炎症和细胞因子风暴的MSC机制的分析.
- 对调查COVID-19的MSC治疗的临床试验进行系统审查.
主要成果:
- MSCs表现出对COVID-19有益的免疫调节特性.
- MSC疗法已经显示出降低与严重COVID-19相关的"细胞因子风暴"的潜力.
- 临床数据表明,MSC疗法在治疗COVID-19患者中是安全且潜在有效的.
结论:
- 介质细胞干细胞疗法代表了一种新且有前途的方法来管理COVID-19.
- 需要进一步的研究和临床试验,以充分确定MSC治疗的作用.
- MSC疗法提供了一种潜在的策略,可以改善COVID-19患者的治疗结果.
更多相关视频
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K


